03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Fuxran : | |
Type | Medicine Authorised |
Originator | Faslodex |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Sandoz |
Responsible Party | Sandoz Pharmaceuticals AG |
Origin | Switzerland |
Manufacturer | Fareva Unterach GmbH |
Manufacturing Type | G |
Origin | Austria |
ATC | L02BA03 |
Fuxran :
Fuxran :
Fuxran :
Fuxran :
Fuxran :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
ALT increased | Very Common |
AST increased | Very Common |
Asthenia | Very Common |
Back pain | Common |
Blood alkaline phosphatase increased | Very Common |
Blood bilirubin increased | Common |
Decreased appetite | Common |
Diarrhoea (Diarrhea) | Common |
Embolism venous | Common |
Gamma-GT increased | Uncommon |
Headache | Common |
Hepatic enzyme increased | Very Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Uncommon |
Hepatitis | Uncommon |
Hot flush | Common |
Hypersensitivity | Common |
Injection site haematoma | Uncommon |
Injection site haemorrhage | Uncommon |
Injection site reaction | Very Common |
Nausea | Very Common |
Platelet count decreased (Thrombocyte count decreased) | Uncommon |
Skin rash | Common |
Urinary tract infection | Common |
Vaginal discharge | Uncommon |
Vaginal haemorrhage | Uncommon |
Vomiting | Common |
Vulvovaginal candidiasis | Uncommon |
Fuxran :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Fuxran MoH 10449 :
Form | Solution for injection |
Packaging | Pre-filled Syringe |
Package Size | 2x5ml |
Strength | 250mg |
Public Price | 603146 L.L. |
Stratum | E1 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 56020/1 |
Submission date | 18/05/2020 |
Registration Year | 02/10/2020 |
Price Comparison
● Country: | UK | |
● Package Size: | 2 | |
● Public Price: | 522.41 GBP | ( 59,371,374.09 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 261,205 GBP | ( 29,662,389.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 2x5ml | |
● Public Price: | 517.2 CHF | ( 53,488,824.00 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 258,6 CHF | ( 26,682,360.00 LBP ) |
● Exfactory Price: | 436.23 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Sweden | |
● Package Size: | 2x5ml | |
● Public Price: | 5273.83 SEK | ( 44,342,362.64 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 2636,915 SEK | ( 22,163,488.00 LBP ) |
● Pharmacy Price: | 5125.08 SEK | ( 43091672.64 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 2x5ml | |
● Public Price: | 264.51 EUR | ( 25,624,670.76 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 132,255 EUR | ( 12,787,632.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 1 | |
● Public Price: | 99.75 EUR | ( 9,663,381.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 99,75 EUR | ( 9,590,724.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Solution for injection | |
● Package Size: | 2x5ml | |
● Public Price: | 603146 LBP | ( 603,146.00 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 301573 LBP | ( 301,573.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Denmark |
● Package Size: | 2x5ml |
● Reference: | Danish Medicine Agency |
● Pricing Date: | 19/05/2021 |
● Type: | Medicine Non Marketed |
● Country: | The Netherlands |
● Package Size: | 2x5ml |
● Reference: | Zorginstituut Nederland |
● Pricing Date: | 15/06/2019 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File